I’m pretty sure the guy behind me thinks I’m a moron. To be clear, I’m not sure that the driver behind the headlights tailing me is a man. And maybe “moron” (or any less polite synonym) isn’t the precise word. The lights have been bearing down on me on this…

Remember, from my very first installment, the prominent biotech investor who knows all of the words to Guys and Dolls? He also knows all of the words to virtually every Rogers and Hammerstein musical ever written, as well as the entire scores of Annie Get Your Gun and Kiss Me…

The sculptor Auguste Rodin knew hands. While he may be known best for his sculpture The Thinker, I’m partial to his hand sculptures. I’m most drawn to one titled The Cathedral, which depicts two hands barely touching each other. Clasping but not quite. The hands themselves look like they are…

Courtney Beers once thought she might become a glass-blower/artist. Now she is the Chief Scientific Officer of Tizona. I was introduced to Courtney by Bizzy Balaraman at Russell Reynolds after I posted my first piece in this series. …

Lis Warren is a biotech professional, a Grammy winner and a jam band fan. Since starting this series, I have had several biotech people remind me of their own experiences in the arts and humanities. Lis worked on my Commercial Pipeline team at Genentech for a period of time, and…

Come From Away is a musical about the week after September 11th, 2001, in a small town in Newfoundland, Canada, called Gander. During the week after the World Trade Center fell, 38 airplanes were grounded in Gander while U.S. air space was shut down. …

I am a big fan of a good cover. One of my favorites is Peter Gabriel’s In Your Eyes by Jeffrey Gaines. It’s a simple, kind of gritty acoustic number that is just as good as the original version but good for different reasons. A few weeks ago, I heard…

There was a time when I had an IUD blindspot. Many of these posts have been about the arts. But let’s bring in a little humanities for all of those history majors out there and talk about some important history. …

It’s a hard time for biotech right now. The stock market seems to have lost faith in our industry’s ability to bring medicines to patients, and biotechs across the board have had a run of bad news — bad data, bad behavior. We see small companies shutting their doors, and…